


Healthcare Industry News: Synergetics USA
News Release - November 26, 2007
Synergetics USA, Inc. Adds New Electrosurgical Generator to Its Neurosurgical Product Line
O'FALLON, Mo.--(HSMN NewsFeed)--Synergetics USA, Inc. (NASDAQ: SURG ) announced today that it will begin producing a lower priced, electrosurgical generator with full feature cut and coagulation modes. The new unit, designed to fill the price range between the small coagulation only unit, COAG, and the up-market AdvantageTM, named Dual WaveTM is designed to address cost compression in the marketplace and dramatically improve sales profit margins. Even though the unit is lower priced, it will contain the patented Malis® waveform.“This unit will provide us with selling options, especially when confronted with the price compression that we’ve seen from competitors,” said Gregg D. Scheller, President and Chief Executive Officer of Synergetics USA, Inc. “This unit can be produced at a much lower cost and will offer an alternative to those customers who are not interested in the full featured AdvantageTM. Although this unit will contain the patented Malis® waveform for coagulation, it will not have the improved cutting ability of the AdvantageTM and will not accept the hand-switched bipolar pencils.”
About Synergetics USA, Inc.
Synergetics USA, Inc. (www.synergeticsusa.com) resulted from the September 2005 combination of Valley Forge Scientific Corp. and Synergetics, Inc., bringing together their respective unique capabilities in bipolar electrosurgical generators and design, and manufacture of microsurgical hand instruments. Synergetics USA, Inc. designs, manufactures and markets medical devices for use primarily in ophthalmic surgery and neurosurgery and for other healthcare applications. Its products are designed and manufactured to support micro or minimally invasive surgical procedures. In addition to its surgical devices and equipment, it designs and manufactures disposable and non-disposable supplies and accessories for use with such devices and equipment. It also manufactures and sells bipolar electrosurgical generators and other generators, based on its DualWaveTM technology, and complementary instrumentation and disposable products for use in neurosurgery, spine surgery, pain control and in dental applications. Synergetics sells its products primarily to hospitals, clinics and surgeons in approximately 70 countries.
Forward-Looking Statements
Some statements in this release may be “forward-looking statements” for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important facts that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These facts, risks and uncertainties are discussed in Synergetics’ Annual Report on Form 10-K for the year ended July 31, 2007, as updated from time to time in our filings with the Securities and Exchange Commission.
Source: Synergetics USA
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
